Referencer
- Achté K. A. On Prognosis and Rehabilitation in Schizophrenic and Paranoid Psychoses. Acta psychiat. scand. 1967; 43, Suppl. 196
- Haase A. D., Frank Th., Knaack M., Lehnhard Ch., Lehnhard Pill H. Klinische Prüfung eines neuen Langzeitneuroleptikums (Fluspirilene) under besonderer Berücksichtigung der neuroleptischen Schwelle. Nervenarzt 1968; 39: 275–279
- Honigfeldt G., Gillis R. D., Klett C. J. Nosie-30: A treatmentsensitive Ward behavior Scale. Psychol. Reports. 1966; 19: 180–182
- Janssen P. A. K., Niemegeers C. J. E., Schellekens K. H.L., Lenaerts F. J., Verbruggen J. M., Van Neuten F. M., Marsboom R. H.M., Hérin V. V., Schaper W. K.A. The pharmacology of fluspirilene (R6218), a potent long-acting and injectable neuroleptic drug. Arzneimittel-Forsch. 1970; 20: 1689–98
- Malm U. Fluphenazin depot. Nord. Psykiat. T. 1971; 25: 309–314
- Sterkmans P., Brugmans J., Gevers F. Clinical evaluation of fluspirilene (R6218), a long-acting injectable neuroleptic. Clin. Trials. J. 1969; 6: 19–25
- Tanghe A. J. L., Vereecken M. Clinical and ergotherapeutic evaluation of fluspirilene (R6218), a long-acting injectable neuroleptic, in chronic psyckotic patients. Psychiat. Neurol. Neurochir. 1971; 74: 379–389
- Tanghe A. J.L., Vereecken M. Fluspirilene, an injectable and penfluridol, an oral long-acting neuroleptic. A comparative double-blind trial in residual schizophrenia. Acta psychiat. scand. 1972; 48: 315–331
- Vereecken, Th MJ. L., Tanghe A. Fluspirilene and pipothiazine undecylenate, two long-acting injectable neuroleptics. A double-blind controlled trial in residual schizophrenia. Psychiat. Neurol. Neurochir. 1972; 74: 117–127
- Villeneuve A., Dogan K., Lachance R., Proulx C. A controlled study of fluspirilene in chronic schizophrenia. Cur. Ther. Res. 1970; 12: 819
- Zwanikken G. K., Remans B., Dewulf P., Amery W. Clinical evaluation of the long-acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally retarded patients. Acta psychiat. scand. 1971; 47: 334–348